Cargando…

Correction to: A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels

Detalles Bibliográficos
Autores principales:	Zhang, Pengzi, Feng, Wenhuan, Chu, Xuehui, Sun, Xitai, Zhu, Dalong, Bi, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027045/ https://www.ncbi.nlm.nih.gov/pubmed/32070293 http://dx.doi.org/10.1186/s12876-020-1181-z

Ejemplares similares

A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels
por: Zhang, Pengzi, et al.
Publicado: (2019)

Correction to: Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes
por: Zhang, Wei, et al.
Publicado: (2022)

Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity
por: Wang, Hongdong, et al.
Publicado: (2019)

Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: a retrospective cohort study
por: Xu, Ping, et al.
Publicado: (2022)

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery
por: Yuan, Xianwen, et al.
Publicado: (2018)

The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases
por: Kaya, Eda, et al.
Publicado: (2020)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Correction: Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease.
por: McMahan, Rachel H., et al.
Publicado: (2016)

Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes
por: Zhang, Wei, et al.
Publicado: (2021)

Weight loss and metabolic benefits of bariatric surgery in China: A multicenter study
por: Feng, Wenhuan, et al.
Publicado: (2023)

Correction: The expanding role of fish models in understanding non-alcoholic fatty liver disease
Publicado: (2014)

Correction: Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
Publicado: (2014)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet
por: Zhang, Ningjing, et al.
Publicado: (2020)

Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
por: Spanos, Christos, et al.
Publicado: (2018)

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review
por: Peuskens, J., et al.
Publicado: (2014)

Correction: Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy
Publicado: (2020)

Serum prolactin and migraine
por: Masoud, S. Ali, et al.
Publicado: (2005)

Correction: High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men
por: Lee, Jieun, et al.
Publicado: (2018)

Correction: Prolactin Secretion in Healthy Adults Is Determined by Gender, Age and Body Mass Index
Publicado: (2014)

Estimation of serum prolactin levels and determination of prevalence of hyperprolactinemia in newly diagnosed cases of subclinical hypothyroidism
por: Sirohi, Tanvi, et al.
Publicado: (2018)

Correction: Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved
por: Eriksen, Peter Lykke, et al.
Publicado: (2023)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

A STUDY OF SERUM PROLACTIN AND PLASMA HUMAN GROWTH HORMONE IN MALE ALCOHOLICS
por: Sengupta, Somnath, et al.
Publicado: (1997)

Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
por: Wan, S., et al.
Publicado: (2019)

Levosulpiride and Serum Prolactin Levels
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2017)

Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
por: Zhang, Jianwei, et al.
Publicado: (2023)

Author Correction: Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women
por: Kang, Danbee, et al.
Publicado: (2020)

Correction: Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India
por: Bhatt, Surya Prakash, et al.
Publicado: (2018)

The Expression of Prolactin Receptors in Benign Breast Tumors Is Not Associated with Serum Prolactin Level
por: Kolomiiets, Olena, et al.
Publicado: (2021)

J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes
por: Zhu, Cuiling, et al.
Publicado: (2022)

The utility of prolactin serial sampling and the best prolactin cut-offs associated with persistent hyperprolactinemia
por: Cidade-Rodrigues, Catarina, et al.
Publicado: (2021)

Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial
por: Gao, Lu-Lu, et al.
Publicado: (2021)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics
por: Chrostek, Lech, et al.
Publicado: (2019)

Noninvasive diagnosis in alcohol‐related liver disease
por: Hadefi, Alia, et al.
Publicado: (2020)

Regional difference in the susceptibility of non-alcoholic fatty liver disease in China
por: Xia, Mingfeng, et al.
Publicado: (2020)

SERUM PROLACTIN CHANGES IN EPILEPSY AND HYSTERIA
por: Tharyan, P., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_6hk79f90eqkp07f4gpckbf5gl3